Cargando…
miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome Editing
Annexin A1 (ANXA1) is a Ca(2+)-binding protein that is involved in pancreatic cancer (PC) progression. It is able to mediate cytoskeletal organization maintaining a malignant phenotype. Our previous studies showed that ANXA1 Knock-Out (KO) MIA PaCa-2 cells partially lost their migratory and invasive...
Autores principales: | Belvedere, Raffaella, Saggese, Pasquale, Pessolano, Emanuela, Memoli, Domenico, Bizzarro, Valentina, Rizzo, Francesca, Parente, Luca, Weisz, Alessandro, Petrella, Antonello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073506/ https://www.ncbi.nlm.nih.gov/pubmed/29986379 http://dx.doi.org/10.3390/ijms19071967 |
Ejemplares similares
-
Annexin A1 Contained in Extracellular Vesicles Promotes the Activation of Keratinocytes by Mesoglycan Effects: An Autocrine Loop Through FPRs
por: Pessolano, Emanuela, et al.
Publicado: (2019) -
Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesicles Effects as Evidenced in the In Vitro MIA PaCa-2 Model System
por: Pessolano, Emanuela, et al.
Publicado: (2018) -
Annexin A1 Induces Skeletal Muscle Cell Migration Acting through Formyl Peptide Receptors
por: Bizzarro, Valentina, et al.
Publicado: (2012) -
Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway
por: Belvedere, Raffaella, et al.
Publicado: (2016) -
Mesoglycan connects Syndecan‐4 and VEGFR2 through Annexin A1 and formyl peptide receptors to promote angiogenesis in vitro
por: Pessolano, Emanuela, et al.
Publicado: (2021)